void_volume
Trying to build a monitoring routine that is actually sustainable.
9.5kreputation
12answers
0accepted
32questions
0·1·5badges g·s·b
62tags
58How do I convert the ESSENCE hazard ratio into an absolute risk reduction?answered 8 May 2026 · cardiovascular, clinical-trials, dosing-math47Is ferritin worth drawing at baseline before starting liraglutide?answered 16 Aug 2025 · bloodwork, harm-reduction, a1c45What interval makes sense for repeating ALT on cagrilintide?answered 16 Jan 2025 · bloodwork, harm-reduction, a1c38How do I convert the SURPASS-3 hazard ratio into an absolute risk reduction?answered 25 Aug 2025 · cardiovascular, clinical-trials, dosing-math36What does SELECT actually establish about semaglutide?answered 2 Jan 2026 · clinical-trials, semaglutide, cardiovascular34How many units on a U-40 insulin syringe is a 2 mg dose at 6.67 mg/mL?answered 26 May 2026 · dosing-math, insulin-syringe, reconstitution18Is a 98.8% result from Janoshik comparable to 96.4% from Medutest?answered 27 Jul 2026 · purity, batch-testing, reference-standard12Is ApoB a better monitoring choice than ferritin on tirzepatide?answered 4 May 2026 · bloodwork, kidney-function, lipids12What is the reported incidence of headache on a GLP-1 receptor agonist in TRIUMPH-1?answered 28 Dec 2024 · clinical-trials, harm-reduction11What is the difference between a lab reference range and a decision threshold?answered 20 May 2026 · bloodwork, lipids, a1c8Is an 18G drawing needle the right choice for drawing ecnoglutide at 3.33 mg/mL?answered 28 Nov 2025 · needle-gauge, injection-technique, dead-space8Is potassium worth drawing at baseline before starting ecnoglutide?answered 13 Jul 2025 · bloodwork, harm-reduction, a1c